Mindfulness Meditation: Impact on Attentional Control and Emotion Dysregulation.

Attention Elderly/geriatrics/aging Emotions/emotional processing Multiple sclerosis

Journal

Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists
ISSN: 1873-5843
Titre abrégé: Arch Clin Neuropsychol
Pays: United States
ID NLM: 9004255

Informations de publication

Date de publication:
13 Oct 2021
Historique:
accepted: 16 06 2021
entrez: 15 10 2021
pubmed: 16 10 2021
medline: 21 10 2021
Statut: ppublish

Résumé

Theoretical models of mindfulness meditation conceptualize the cultivation of focused attention and regulation of emotional states, with the attitudinal foundations that promote nonjudgment and acceptance, to facilitate cognitive and affective processing resulting in improved brain health. Within the scientific study of mindfulness meditation, outcomes assessing behavioral and neural correlates of attentional control and emotion regulation have been examined for their malleability as a function of engagement in mindfulness practices. This review synthesizes the results of our pilot trials examining the preliminary effects of mindfulness meditation on metrics of cognitive, affective, and brain health in older adults and in individuals with multiple sclerosis. There is promising support for mindfulness meditation to enhance attentional control, reduce mind-wandering, and reduce emotion dysregulation. However, well-powered efficacy trials, with an objective assessment of mindfulness practice data are needed to further provide causal and comprehensive evidence supporting the efficacy of mindfulness meditation for brain health. Inclusion of independently derived and validated brain-based signatures of cognitive and affective functioning can additionally enable a parsimonious understanding of how mindfulness meditation can causally impact metrics of functional and structural integrity of the human brain.

Identifiants

pubmed: 34651648
pii: 6396900
doi: 10.1093/arclin/acab053
pmc: PMC8517620
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1283-1290

Subventions

Organisme : NIA NIH HHS
ID : R01 AG054427
Pays : United States
Organisme : National Multiple Sclerosis Society
ID : PP2183
Organisme : NIH HHS
ID : R01AG054427
Pays : United States

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Clin Psychol Rev. 2018 Feb;59:52-60
pubmed: 29126747
Perspect Psychol Sci. 2013 Jul;8(4):445-54
pubmed: 26173122
J Exp Psychol Gen. 2012 Feb;141(1):106-23
pubmed: 21910559
Lancet. 2016 Nov 5;388(10057):2272-2281
pubmed: 27692469
Explore (NY). 2017 Jan - Feb;13(1):26-45
pubmed: 27889445
Lancet. 2002 Apr 6;359(9313):1221-31
pubmed: 11955556
J Int Neuropsychol Soc. 2018 Sep;24(8):876-888
pubmed: 30153873
Neuropsychology. 2020 Jul;34(5):591-604
pubmed: 32352832
J Cogn Neurosci. 2018 Feb;30(2):160-173
pubmed: 29040013
Psychol Sci. 2013 May;24(5):776-81
pubmed: 23538911
Conscious Cogn. 2016 Aug;44:193-204
pubmed: 27541935
Biol Psychiatry. 2016 Jul 1;80(1):53-61
pubmed: 27021514
Rehabil Psychol. 2020 Aug;65(3):206-218
pubmed: 32378922
Am J Psychiatry. 2010 Jul;167(7):748-51
pubmed: 20595427
Clin Psychol Rev. 2010 Mar;30(2):217-37
pubmed: 20015584
Nat Rev Immunol. 2015 Sep 15;15(9):545-58
pubmed: 26250739
Mult Scler Relat Disord. 2019 Nov;36:101399
pubmed: 31557680
Medicine (Baltimore). 2020 Jul 10;99(28):e20493
pubmed: 32664060
Mult Scler. 2015 Mar;21(3):263-81
pubmed: 25623244
Psychol Bull. 2006 Nov;132(6):946-958
pubmed: 17073528
Disabil Rehabil. 2014;36(12):987-92
pubmed: 23962192
Nat Neurosci. 2016 Jan;19(1):165-71
pubmed: 26595653
Perspect Psychol Sci. 2011 Nov;6(6):537-59
pubmed: 26168376
J Neurosci. 2009 Feb 11;29(6):1860-73
pubmed: 19211893
Cereb Cortex. 2013 Nov;23(11):2712-23
pubmed: 22941724
J Psychosom Res. 2016 Oct;89:1-6
pubmed: 27663102
J Clin Neurosci. 2019 Oct;68:211-217
pubmed: 31303397
Rev Neurosci. 2018 Sep 25;29(7):791-804
pubmed: 29466242
Neurology. 2019 Mar 5;92(10):e1029-e1040
pubmed: 30770430
Cogn Affect Behav Neurosci. 2015 Sep;15(3):712-20
pubmed: 25904238
Trends Cogn Sci. 2017 Apr;21(4):290-302
pubmed: 28238605
Ann Behav Med. 2017 Apr;51(2):199-213
pubmed: 27658913
J Psychosom Res. 2014 May;76(5):341-51
pubmed: 24745774
Annu Rev Neurosci. 1990;13:25-42
pubmed: 2183676
Acta Neurol Scand. 2001 Nov;104(5):257-61
pubmed: 11696017
Eur Endocrinol. 2018 Apr;14(1):35-41
pubmed: 29922350
Psychiatry Res. 2011 Jan 30;191(1):36-43
pubmed: 21071182
Gen Hosp Psychiatry. 1982 Apr;4(1):33-47
pubmed: 7042457
Clin Psychol Sci. 2014 Jan 1;2(1):22-34
pubmed: 25821658
Ir J Psychol Med. 2018 Jun;35(2):89-94
pubmed: 30115193
Nat Protoc. 2017 Mar;12(3):506-518
pubmed: 28182017
World Psychiatry. 2015 Jun;14(2):154-7
pubmed: 26043324
J Neurosci. 2016 Sep 14;36(37):9547-57
pubmed: 27629707
J Clin Psychol. 2012 Jul;68(7):755-65
pubmed: 22623334
Disabil Rehabil. 2014;36(13):1128-32
pubmed: 24041009
J Med Internet Res. 2017 Aug 31;19(8):e303
pubmed: 28860106
J Cogn Enhanc. 2020 Sep;4(3):340-367
pubmed: 33817547
Soc Cogn Affect Neurosci. 2019 Jul 31;14(7):777-787
pubmed: 31269203
Neuroimage. 2019 Feb 1;186:1-13
pubmed: 30394324

Auteurs

Ruchika Shaurya Prakash (RS)

The Ohio State University, Department of Psychology, 1835 Neil Ave Columbus, OH 43210 USA.
The Ohio State University, Center for Cognitive and Behavioral Brain Imaging, 1835 Neil Ave Columbus, OH 43210 USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH